Exercise and Patient Education Compared With Usual Care in Patients With Hip Dysplasia
MovetheHip
MovetheHip-trial: The Effectiveness of Exercise and Patient Education Compared With Usual Care on Self-reported Pain in Patients With Hip Dysplasia
1 other identifier
interventional
200
1 country
2
Brief Summary
This effectiveness trial will investigate if patients with hip dysplasia randomised to exercise and patient education have a different mean change in self-reported pain measured by the Copenhagen Hip and Groin Outcome Score (HAGOS) compared with those randomised to usual care over a six-month follow-up period. Participating patients will be allocated to either exercise and patient education or usual care. Alongside this, a health-economic study and a process-evaluation study will be conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2021
CompletedFirst Posted
Study publicly available on registry
March 12, 2021
CompletedStudy Start
First participant enrolled
April 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
December 5, 2025
November 1, 2025
6.2 years
March 9, 2021
December 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in self-reported pain measured with The Copenhagen Hip and Groin Outcome Score (HAGOS) (continuous data)
HAGOS pain sub-item measures degree of hip and/or groin pain through ten individual questions on a score from 0 to 100, higher score indicates lower pain.
From baseline to 6-month follow-up. Outcome measured at baseline, 3- and 6-month follow-up. In addition at 9- and 12-month follow-up (health economic study) and after 2, 5 and 10 years (describing if hip osteoarthritis progresses over time)
Secondary Outcomes (13)
Change in self-reported symptoms measured with HAGOS (continuous data)
From baseline to 6-month follow-up. Outcome measured at baseline, 3- and 6-month follow-up. In addition at 9- and 12-month follow-up and after 2, 5 and 10 years (describing if hip osteoarthritis progresses over time)
Change in self-reported physical function, daily living (ADL) measured with HAGOS (continuous data)
From baseline to 6-month follow-up. Outcome measured at baseline, 3- and 6-month follow-up. In addition at 9- and 12-month follow-up and after 2, 5 and 10 years (describing if hip osteoarthritis progresses over time)
Change in self-reported physical function in sports and recreational activities (sport/recreation) measured with HAGOS (continuous data)
From baseline to 6-month follow-up. Outcome measured at baseline, 3- and 6-month follow-up. In addition at 9- and 12-month follow-up and after 2, 5 and 10 years (describing if hip osteoarthritis progresses over time)
Change in self-reported participation in physical activities (participation) measured with HAGOS (continuous data)
From baseline to 6-month follow-up. Outcome measured at baseline, 3- and 6-month follow-up. In addition at 9- and 12-month follow-up and after 2, 5 and 10 years (describing if hip osteoarthritis progresses over time)
Change in self-reported quality of life (QOL) measured with HAGOS (continuous data)
From baseline to 6-month follow-up. Outcome measured at baseline, 3- and 6-month follow-up. In addition at 9- and 12-month follow-up and after 2, 5 and 10 years (describing if hip osteoarthritis progresses over time)
- +8 more secondary outcomes
Other Outcomes (23)
Self-reported acceptable symptom state using the Patient Acceptable Symptom State (PASS) (dichotome data)
Measured at 6- and 12-month follow-up
Change in self-reported hip and/or groin pain intensity measured with a 100 mm Visual Analogue Scale (VAS) for pain in rest (continuous data)
From baseline to 6-month follow-up. Outcome measured at baseline, 6- and 12-month follow-up
Change in self-reported hip and/or groin pain intensity measured with a 100 mm Visual Analogue Scale (VAS) for pain during physical activity (continuous data)
From baseline to 6-month follow-up. Outcome measured at baseline, 6- and 12-month follow-up
- +20 more other outcomes
Study Arms (2)
Exercise and patient education
EXPERIMENTAL6-months
Usual Care
ACTIVE COMPARATOR6-months
Interventions
Over a period of 6-months, patients will be offered eight one-to-one supervised training sessions. In these sessions, patients will be instructed in a home-based exercise programme and given patient education. The programme includes four exercises covering strength and stability training. The exercises will be performed in sets of three with a minimum of 5 repetitions, and patients will be instructed to perform a minimum of three training sessions each week. Each of the exercises can be progressed through three levels of difficulty, allowing for individualised treatment with regard to exercise quality and perceived exertion according to the Borg CR10 scale. Exercises will be performed on a perceived exertion level from somewhat hard (level 5) to very hard (level 7). Patient education includes pain management, a focus on exercise adherence and progression, and advice on physical activity.
Patients will follow usual care, including an individual consultation on self-management of hip symptoms and general advice on exercise and physical activity.
Eligibility Criteria
You may qualify if:
- Radiographically verified hip dysplasia by a Wiberg's centre edge (CE) angle of 10-25 degrees and an acetabular Index (AI) angle \>10 degrees
- Hip and/or groin pain as primary pain for at least three months
- Candidate for periacetabular osteotomy (PAO) but unwilling to undergo PAO, or on a waiting list for surgery (PAO) for 12 months or longer
- Not candidate for PAO (negative impingement test, BMI \>25, hip osteoarthritis, age \>45 years or reduced hip range of motion)
You may not qualify if:
- Self-reported pain score \>80 points measured with Copenhagen Hip and Groin outcome score
- Any major planned surgery (i.e. arthroplastic surgery or discectomy surgery)
- BMI \>35
- Acetabular retroversion defined by crossover sign and posterior wall sign
- Calvé Legg Perthes or epiphysiolysis
- Previous pelvic/hip surgery in index limb
- Previous pelvic/hip surgery within the last 2 years in contralateral limb
- Previous surgery due to herniated disc or spondylodesis
- Previous arthroplastic surgery in the hip, knee or ankle
- Physical (pregnancy/trauma), neurological, medical or rheumatic conditions severely affecting the hip function
- Inadequacy in written and spoken Danish, mental illness or other conditions affecting the ability to follow mandatory procedures for participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- VIA University Collegecollaborator
- Research Unit for General Practice, Aarhus Universitycollaborator
- Copenhagen University Hospital, Hvidovrecollaborator
- Defactum, Central Denmark Regioncollaborator
Study Sites (2)
Aarhus University Hospital
Aarhus N, 8200, Denmark
Silkeborg Regional Hospital.
Silkeborg, 8600, Denmark
Related Publications (3)
Jacobsen JS, Evans R, Morgan K, Thorborg K, Oestergaard LG, Sorensen D. An exercise and patient education intervention to reduce pain and physical limitations in adults with acetabular dysplasia: study protocol for a process evaluation integrated within a randomised controlled trial (the MovetheHip trial). Trials. 2024 Jun 24;25(1):411. doi: 10.1186/s13063-024-08262-y.
PMID: 38915128BACKGROUNDJacobsen JS, Thorborg K, Nielsen RO, Jakobsen SS, Foldager C, Sorensen D, Oestergaard LG, van Tulder MW, Mechlenburg I. Comparing exercise and patient education with usual care in the treatment of hip dysplasia: a protocol for a randomised controlled trial with 6-month follow-up (MovetheHip trial). BMJ Open. 2022 Sep 20;12(9):e064242. doi: 10.1136/bmjopen-2022-064242.
PMID: 36127096BACKGROUNDJacobsen JS, Thorborg K, Sorensen D, Jakobsen SS, Nielsen RO, Oestergaard LG, Soballe K, Mechlenburg I. Feasibility and acceptability of a six-month exercise and patient education intervention for patients with hip dysplasia: A mixed methods study. Musculoskelet Sci Pract. 2022 Oct;61:102615. doi: 10.1016/j.msksp.2022.102615. Epub 2022 Jun 24.
PMID: 35820302BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julie S Jacobsen, PhD
VIA University College
- STUDY DIRECTOR
Inger Mechlenburg, DMSc
Aarhus University Hospital
- STUDY CHAIR
Kristian Thorborg, PhD
Copenhagen University Hospital, Hvidovre
- STUDY CHAIR
Rasmus Ø Nielsen, PhD
University of Aarhus
- STUDY CHAIR
Stig S Jakobsen, PhD
Aarhus University Hospital
- STUDY CHAIR
Lisa G Oestergaard, PhD
Defactum, Central Denmark Region
- STUDY CHAIR
Kjeld Søballe, PhD
Aarhus University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2021
First Posted
March 12, 2021
Study Start
April 16, 2021
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
December 5, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Immediately following publication and ending 5 years following primary article publication.
- Access Criteria
- Proposals should be directed to jsaj@via.dk. To gain access, data requestors will need to sign a data access agreement.
What data will be shared: All quantitative individual participant data collected during the trial, after deidentification. With whom will data be shared: Researchers who provide a methodologically sound proposal. For what types of analyses: To achieve aims in the approved proposal. The abovementioned is based on Data Sharing Statements for Clinical Trials: A Requirement of the ICMJE located at: http://www.icmje.org/news-and-editorials/data\_sharing\_june\_2017.pdf.